Abstract
Congenital infections are those that are acquired transplacentally by the fetus from an infected mother. They constitute a major public health burden, affecting millions of infants and children worldwide. Despite significant advances in medical diagnostics, the majority of newborns with congenital infections are not recognized, since many of these infections may not cause clinically - apparent disease in the newborn period. Nonetheless, these infections - whether they are apparent or silent - have the potential to adversely impact the neurodevelopmental outcomes of these vulnerable children.
Keywords: Cytomegalovirus, CMV, congenital infection, HIV, rubella, syphilis, toxoplasmosis, congenital syphilis, herpes simplex virus (HSV), Lyme disease, valganciclovir, Screening, newborns, Obstetricians
Infectious Disorders - Drug Targets
Title: Overview of Congenital Infections: The Prominence of Cytomegalovirus
Volume: 11 Issue: 5
Author(s): Joseph B. Cantey and Pablo J. Sanchez
Affiliation:
Keywords: Cytomegalovirus, CMV, congenital infection, HIV, rubella, syphilis, toxoplasmosis, congenital syphilis, herpes simplex virus (HSV), Lyme disease, valganciclovir, Screening, newborns, Obstetricians
Abstract: Congenital infections are those that are acquired transplacentally by the fetus from an infected mother. They constitute a major public health burden, affecting millions of infants and children worldwide. Despite significant advances in medical diagnostics, the majority of newborns with congenital infections are not recognized, since many of these infections may not cause clinically - apparent disease in the newborn period. Nonetheless, these infections - whether they are apparent or silent - have the potential to adversely impact the neurodevelopmental outcomes of these vulnerable children.
Export Options
About this article
Cite this article as:
B. Cantey Joseph and J. Sanchez Pablo, Overview of Congenital Infections: The Prominence of Cytomegalovirus, Infectious Disorders - Drug Targets 2011; 11 (5) . https://dx.doi.org/10.2174/187152611797636677
DOI https://dx.doi.org/10.2174/187152611797636677 |
Print ISSN 1871-5265 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3989 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Daptomycin: A Review of Properties, Clinical Use, Drug Delivery and Resistance
Mini-Reviews in Medicinal Chemistry Minocycline and Doxycycline: More Than Antibiotics
Current Molecular Pharmacology CSF as a Surrogate for Assessing CNS Exposure: An Industrial Perspective
Current Drug Metabolism The Blood Brain Barrier, Mechanisms of Cerebral Edema, and the Use of Anti-Inflammatory and other Anti-Edema Agents in Neuro-Oncology
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Synthesis and Antibacterial Activity of New Chalcones Bearing an Imidazo[ 1,2-a]pyridine Moiety
Current Chemical Biology Mixed Connective Tissue Disease (MCTD) – A Coming of Age
Current Rheumatology Reviews COX-2 in Brain and Spinal Cord - Implications for Therapeutic Use.
Current Medicinal Chemistry Fluoroquinolones in Pediatrics
Current Drug Therapy Atranorin – An Interesting Lichen Secondary Metabolite
Mini-Reviews in Medicinal Chemistry Antifungal Drug Discovery through the Study of Invertebrate Model Hosts
Current Medicinal Chemistry Anti-Infective Strategies of the Future: Is there Room for Species-Specific Antibacterial Agents?
Current Pharmaceutical Design Tuberculosis: Challenges to Improve the Treatment
Current Clinical Pharmacology Role of Resveratrol in Modulating microRNAs in Human Diseases: From Cancer to Inflammatory Disorder
Current Medicinal Chemistry Nanotools for the Delivery of Antimicrobial Peptides
Current Drug Targets Update on Childhood Brucellosis
Recent Patents on Anti-Infective Drug Discovery Vaccination and Antiviral Treatment of Neglected Diseases Caused by Flaviviral Infections
Current Medicinal Chemistry Emerging Treatments in Acute Lymphoblastic Leukemia
Current Cancer Drug Targets The Patenting and Technological Trends in Candidiasis Treatment: A Systematic Review (2014-2018)
Current Topics in Medicinal Chemistry Lipid-Based Nanoparticulate Systems for the Delivery of Anti-Cancer Drug Cocktails: Implications on Pharmacokinetics and Drug Toxicities
Current Drug Metabolism Membrane Targeted Chemotherapy with Hybrid Liposomes for Tumor Cells Leading to Apoptosis
Current Pharmaceutical Design